Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more) Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Healthcare Biotechnology
Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care... see more

Recent & Breaking News (TSXV:COV)

Covalon Announces Issuance of Stock Options

Business Wire December 21, 2017

Covalon Announces Record Positive Results for Fiscal 2017

Business Wire December 18, 2017

US Major General Gale S. Pollock (Ret.) Joins Covalon’s Board of Directors

Business Wire November 14, 2017

Covalon Announces Issuance of Stock Options

Business Wire October 27, 2017

OTC Markets Group Announces Quarterly Index Performance and Rebalancing

PR Newswire October 13, 2017

Covalon to Feature its Advanced Wound Management and Infection Prevention Lines at Limb Salvage and Woundcare Symposium

Business Wire October 5, 2017

Covalon Announces Major Milestone: FDA Clearance for MediClear™ PreOp

Business Wire September 21, 2017

Covalon Announces the Commencement of Trading on the OTCQX Market in the United States

Business Wire September 18, 2017

OTC Markets Group Welcomes Covalon Technologies to OTCQX

PR Newswire September 18, 2017

Covalon Announces $14 Million in New Contract Orders in the Middle East

Business Wire September 5, 2017

Covalon Announces Conference Call to Discuss Q3 Financial Results

Business Wire August 18, 2017

Covalon To Feature IV Clear at APHON Pediatric Conference

Business Wire August 17, 2017

Covalon Announces First Time Attendance at the 32nd Annual Oley Consumer/Clinician Conference

Business Wire July 6, 2017

Covalon Announces Issuance of Stock Options

Business Wire June 21, 2017

Covalon Announces Voting Results from 2017 Annual Meeting of Shareholders

Business Wire June 16, 2017

Covalon Annual Shareholders’ Meeting to Be Held June 15th 2017 at 3:30pm

Business Wire June 8, 2017

Covalon Chairman Announces Exercise of Warrants and Acquisition of Additional Shares and Warrants

Business Wire June 1, 2017

Affiliate of Goldfarb Corporation Acquires Additional Shares and Warrants of Covalon

Business Wire June 1, 2017

Covalon Announces Closing of Non-Brokered Private Placement and Exercise of Warrants

Business Wire June 1, 2017

Covalon Releases Second Quarter Financial Results

Business Wire May 29, 2017